0012 GMT - Mondelez's CEO said the broader snacking category is not diminishing due to consumers' focus on health and wellness. There hasn't been any noticeable decrease in snacking consumption due to GLP-1 medications, either, Dirk Van de Put said. "Since COVID, the indulgence part of snacking is growing just as fast as the healthy part," he said. The snack giant reported a profit of $1.75 billion for the fourth quarter, compared with $950 million a year earlier. (roshan.fernandez@wsj.com)

(END) Dow Jones Newswires

February 04, 2025 19:13 ET (00:13 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.